PubMed:11773892 / 0-130 JSONTXT

{"project":"LitCoin-entities","denotations":[{"id":"404","span":{"begin":0,"end":23},"obj":"DiseaseOrPhenotypicFeature"},{"id":"405","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"},{"id":"406","span":{"begin":83,"end":94},"obj":"GeneOrGeneProduct"}],"attributes":[{"id":"A1","pred":"db_id","subj":"404","obj":"MESH:D007676"},{"id":"A2","pred":"db_id","subj":"405","obj":"MESH:D007676"},{"id":"A3","pred":"db_id","subj":"406","obj":"NCBIGene:5530"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":0,"end":3},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":48,"end":53},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":83,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":95,"end":100},"obj":"GeneOrGeneProduct"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":48,"end":53},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":83,"end":94},"obj":"GeneOrGeneProduct"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":0,"end":23},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"D007676"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"D007676"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":83,"end":94},"obj":"GeneOrGeneProduct"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0004375"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":0,"end":23},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"D007676"},{"id":"A2","pred":"ID:","subj":"T2","obj":"D007676"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":0,"end":23},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"D007676"},{"id":"A2","pred":"#label","subj":"T2","obj":"D007676"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T86974","span":{"begin":83,"end":94},"obj":"GeneOrGeneProduct"},{"id":"T32133","span":{"begin":25,"end":29},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T82909","span":{"begin":0,"end":23},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A52045","pred":"#label","subj":"T32133","obj":"D007676"},{"id":"A1231","pred":"#label","subj":"T82909","obj":"D007676"}],"text":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of develo"}